A Registered Cohort Study on Duchenne Muscular Dystrophy

Recruiting now

Conditions studied: Duchenne Muscular Dystrophy

In brief

Dystrophinopathy is a term of X-linked recessive genetic disease, including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and the X-linked dilated cardiomyopathy. The aim of this study is to determine the clinical spectrum and natural progression of dystrophinopathy in a prospective multicenter natural history study, to assess the clinical, genetic of patients with dystrophinopathy to optimize clinical management.

Key facts

Study ID

NCT04012671

Run by

Ning Wang, MD., PhD.

People needed

2000

Starts

2019-07-01

Expected to finish

2049-12-31

Last updated by the study team

2021-03-22

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Beyond 2 years old
• Diagnosis with Duchenne Muscular Dystrophy, and female carriers, genotypically confirmed
• Diagnosis should be supported by muscle biopsy, if no genetic confirmation.

You may not qualify if…

• Presence of other clinically significant illness

Where it is running

• First Affiliated Hospital of Fujian Medical University — Fuzhou, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.